Breaks Categories: News

ThursdayFeb 06, 2020 11:08 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Meets Nasdaq Minimum Bid Price Requirement, Regains Compliance

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced its February 4, 2020 receipt of notice from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule") for continued listing on The Nasdaq Capital Market. Accordingly, the company has regained compliance with the Bid Price Rule and Nasdaq considers the matter closed. To view the full press release, visit http://nnw.fm/Fi5Dq About Genprex, Inc. Genprex, Inc. is…

Continue Reading

ThursdayFeb 06, 2020 10:14 am

NetworkNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Launch of Smart Screen Immersive Education Classes in Fujian, China Preschools

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality ("AR") interactive entertainment games, toys and educational materials in China, today announced the launch of a new educational product, "Smart Screen Immersive Education Classes," that will be implemented in preschools in Fujian, China. According to the update, the classes are the first initiative to be announced as part of Blue Hat's new range of immersive educational products using technology to improve teaching in preschools in China. “Blue Hat's Smart Screen Immersive Education Classes are already being used in more than 10 preschools across the provinces…

Continue Reading

ThursdayFeb 06, 2020 10:07 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) CFO Discusses Solar Subsidiary’s Growth and Scalability in Cleantech and Climate Change Podcast

SinglePoint (OTCQB: SING) was featured on today's edition of the Cleantech and Climate Change Podcast. Issued by Investorideas.com, a global news source and leading investor resource covering cleantech and renewable energy stocks (Renewableenergystocks.com), the podcast covers today's problems and solutions for the future. Today's special edition features SinglePoint Chief Financial Officer Corey A. Lambrecht in an exclusive interview where he discusses the company's solar subsidiary, Direct Solar, and his vision for growth and scalability. “What we are looking for as we get into a full year’s worth of growth, is to really accelerate those revenues on the residential side and…

Continue Reading

ThursdayFeb 06, 2020 9:34 am

NetworkNewsBreaks – Marijuana Company of America, Inc. (MCOA) Issues Update on Global Sales, Marketing Strategy for hempSMART Subsidiary

Marijuana Company of America (OTCQB: MCOA), an innovative hemp and cannabis corporation, on Wednesday provided hempSMART's overview for global sales and its marketing strategy for 2020. HempSMART(TM) will be attending the USA CBD Conference at the Las Vegas Convention Center, taking place February 12 -15, 2020. The event will kick-off a global tour of industry-focused conferences enabling hempSMART to connect with more than 11,000 attendees in each regional city and position itself as an industry leader. The tour will also deliver increased exposure, brand positioning and sales expansion, while the network marketing group grows. “With this new rebranding, our premium-quality…

Continue Reading

WednesdayFeb 05, 2020 3:12 pm

NetworkNewsBreaks – DSP Group Inc. (NASDAQ: DSPG) Featured in ROTH Equity Research Report

DSP Group (NASDAQ: DSPG) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “DSPG will report 4Q19 earnings next week. We are encouraged that CY20 growth at DSPG can be supported by ramp of programs across multiple segments, offsetting macro impact on mature cordless telephone business. We expect DSPG to benefit from its strong design win traction and drive steady sequential growth in the CY20 timeframe. We maintain our Buy rating.” To request access to the full report, visit http://nnw.fm/DXCr3 About DSP Group DSP Group(R), Inc. (NASDAQ: DSPG) is a global leader…

Continue Reading

WednesdayFeb 05, 2020 3:08 pm

NetworkNewsBreaks – Inovio Pharmaceuticals, Inc. (NASDAQ: INO) and Beijing Advaccine Partnership Featured in ROTH Equity Research Report

Inovio Pharmaceuticals (NASDAQ: INO) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “INO partnered with Beijing Advaccine, a China-based company focused on discovering new preventive and therapeutic vaccines, to facilitate clinical trial initiation of INO's new coronavirus vaccine, INO-4800, in China. In our view, testing a preventative vaccine close to the source of an epidemic is a truer test of vaccine utility, and collaborating with a local partner will likely grease the wheels of commercial adoption, if successful, in a distant foreign country.” To request access to the full report, visit…

Continue Reading

WednesdayFeb 05, 2020 3:04 pm

NetworkNewsBreaks – Akoustis Technologies, Inc. (NASDAQ: AKTS) Featured in ROTH Equity Research Report

Akoustis Technologies (NASDAQ: AKTS) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “AKTS will report F2Q20 (Dec.) earnings next week. We have gained increased confidence into our AKTS forecast revenue ramp for the remainder of FY20 supported by multiple programs ramping across WiFi, wireless infrastructure and military end markets. We also believe the recent fund-raising has positioned the company to execute well on its product, end market and manufacturing capacity plans. We maintain our Buy rating.” To request access to the full report, visit http://nnw.fm/DXCr3 About Akoustis Technologies, Inc. Akoustis(R) is…

Continue Reading

WednesdayFeb 05, 2020 2:37 pm

NetworkNewsBreaks – Select Companies to Showcase Their Stories for Qualified Investors at 4th Annual Emerging Growth Spring Invitational

Veyo Partners together with Diamond Equity Research will host the 4th Annual Emerging Growth Spring Invitational to be held in New York City next month. A select group of small-cap companies will take the stage and showcase their stories to a highly qualified group of accredited and institutional investors at the event, slated to take place at NYC’s The Cornell Club from 5:30 to 9:00 PM on March 26, 2020. “We have hand selected a group of quality presenting companies for the Emerging Growth Spring Invitational,” Veyo Partners Senior Vice President Shane Vultee said in the news release. “Together with…

Continue Reading

WednesdayFeb 05, 2020 2:32 pm

NetworkNewsBreaks – SinglePoint, Inc.’s (SING) Direct Solar America Continues to Drive New Business as 2020 Initiatives Start to Take Shape

SinglePoint (OTCQB: SING) today announced that its subsidiary, Direct Solar America, continues to drive new business as 2020 sales and marketing initiatives start to take shape. Last week Direct Solar America experienced that increase in business with one of its biggest weeks to date in new contract development. The increase is attributed mainly to new marketing and sales development including new canvassing teams, customer service improvements and increased engagement of partnership channels. “We are strongly committed to continuing the development and improvement of Direct Solar America. The company’s model continues to impress us by the ability to scale with few…

Continue Reading

WednesdayFeb 05, 2020 1:37 pm

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) to Focus Clinical Efforts on Oncoprex(TM) in Combination with Osimertinib for Treatment of Non-Small Cell Lung Cancer

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today provided a clinical update and focus for its Oncoprex(TM) immunogene therapy program for 2020. According to the update, Genprex will prioritize the development of Oncoprex in combination with osimertinib for the treatment of non-small cell lung cancer (“NSCLC”). Genprex, on January 14, 2020, received U.S Food and Drug Administration (“FDA”) Fast Track Designation for its Oncoprex immunogene therapy in combination with the EGFR tyrosine kinase inhibitor osimertinib (AstraZeneca’s Tagrisso(R), currently its highest grossing product) for the…

Continue Reading